Response to Ipilimumab and Nivolumab in a Patient With Malignant Peritoneal Mesothelioma. | EBSCOhost

Connecting you to content on EBSCOhost

Title: Response to Ipilimumab and Nivolumab in a Patient With Malignant Peritoneal Mesothelioma.
Authors: Rizzolo, Angelo; Kenny Chia Ah-Lan; Tuyet Nhung Ton Nu; Alcindor, Thierry
Publication: Clinical Colorectal Cancer, 2022, Vol 21, Issue 4, p371
ISSN: 1533-0028
Publication type: Academic Journal
DOI: 10.1016/j.clcc.2022.08.001